Oppenheimer Holdings Inc (OPY)
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-10-29
$107.94+0.99%
Close 2026-10-29 · 1-day change
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-10-29
Research Workspace
Put OPY beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Investment Banking & Brokerage is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Achieve EPS of at least $4.21 in Q2 2026: Diluted EPS: $2.38 per share.
View ThesisRevenue growth is accelerating — up about 21% over the past year.
View GrowthMiddle-of-the-pack management execution.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskOPY rests on earnings strength, yet reported profits lack cash backing. Revenue grew 21.9% year over year in Q2 FY2026. The latest recorded diluted EPS was $2.38, below the $4.21 Q2 target. OPY trades at 10× P/E versus a 17× peer median. The market prices in more growth than our forecast. Weak cash backing and the broken Q2 EPS pillar threaten the thesis. Our model puts the next-quarter miss probability near 26%. Peer multiples imply a price about 23% above where it trades. The thesis has broken; this read is provisional.
Trailing returns as of 2026-10-29. OPY is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare OPY with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| OPY Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 7 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Investment Banking & Brokerage — fair value, gap to price, and forward P/E.
Compare the value case
Put OPY next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Drive growth in Wealth Management and Capital Markets
AI shift aligns with growth in Wealth Management and Capital Markets.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Negative sentiment from hedge funds could impact stock performance.